Aurobindo Pharma Gets Final Nod For Nevirapine Tablets And Oral Suspension - RTT News

(RTTNews) - Manufacturer of generic pharmaceuticals and active pharmaceutical ingredients Aurobindo Pharma Ltd. said it had received final approval for its tentatively approved ANDAs for Nevirapine tablets 200mg covered under ANDA 077521 and Nevirapine ...

Mylan launches HIV-drug Nevirapine in US - pharmabiz.com

Mylan Inc's subsidiary Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nevirapine tablets USP, 200 mg. This product is the generic version of ...

Mylan Receives FDA Approval For Generic Version Of Viramune Tablets - NASDAQ

(RTTNews.com) - Mylan Inc. (MYL) announced Wednesday that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration or FDA for its Abbreviated New Drug Application or ANDA for Nevirapine ...

Mylan Launches Generic Version of Viramune® Tablets - Yahoo Finance

(1) Mylan CEO Heather Bresch said: "The launch of Nevirapine Tablets, 200 mg, in the U.S. further expands the reach of Mylan's global ARV portfolio. Currently, approximately one-third of HIV/AIDS patients in developing countries depend on a ...

Mylan Launches Generic Viramune Tablets - Monthly Prescribing Reference

Mylan announced the launch of Nevirapine tablets 200mg, the generic version of Boehringer Ingelheim's Viramune tablets 200mg. Viramune is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for combination antiretroviral treatment of HIV-1 infection.

HIV test kits shortage hits pregnant women - deccanchronicle.com

The administration of Nevirapine drug on HIV positive pregnant mothers visiting state-run maternity hospitals in Warangal city has come to a standstill due to non-supply of HIV test kits by Andhra Pradesh State Aids Control Society (APSACS). The contract ...

More Generic Launches for Mylan - Yahoo Finance

for its generic version of Boehringer Ingelheim’s Viramune (nevirapine). Viramune is approved for HIV-1 infection in combination with antiretroviral (:ARV) treatment. According to IMS Health, Viramune generated U.S. revenues of approximately $ ...

FDA OKs Aurobindo's generic of Boehringer's HIV drug Viramune - SmartBrief

Want to see more news summaries? Sign up for AHIP Solutions SmartBrief AHIP Solutions SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news ...

China Biotech In Review: Surgical Instrument Acquisition Takes Mindray Into New Territory - Seekingalpha.com

Zhejiang Huahai Pharmaceutical (SHE: 600521) and Breckenridge Pharma of the US signed an exclusive marketing and distribution agreement for Huahai's HIV drug Nevirapine. Breckenridge will market Nevirapine, a generic version of Boehringer Ingelheim's ...